Correlation Between Bristol Myers and ABPRO P

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and ABPRO P at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and ABPRO P into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and ABPRO P, you can compare the effects of market volatilities on Bristol Myers and ABPRO P and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of ABPRO P. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and ABPRO P.

Diversification Opportunities for Bristol Myers and ABPRO P

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bristol and ABPRO is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and ABPRO P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABPRO P and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with ABPRO P. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABPRO P has no effect on the direction of Bristol Myers i.e., Bristol Myers and ABPRO P go up and down completely randomly.

Pair Corralation between Bristol Myers and ABPRO P

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.18 times more return on investment than ABPRO P. However, Bristol Myers Squibb is 5.43 times less risky than ABPRO P. It trades about 0.12 of its potential returns per unit of risk. ABPRO P is currently generating about -0.35 per unit of risk. If you would invest  5,577  in Bristol Myers Squibb on September 1, 2024 and sell it today you would earn a total of  345.00  from holding Bristol Myers Squibb or generate 6.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Bristol Myers Squibb  vs.  ABPRO P

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.
ABPRO P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABPRO P has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Bristol Myers and ABPRO P Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and ABPRO P

The main advantage of trading using opposite Bristol Myers and ABPRO P positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, ABPRO P can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABPRO P will offset losses from the drop in ABPRO P's long position.
The idea behind Bristol Myers Squibb and ABPRO P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets